Characterization of a re‐engineered, mesothelin‐targeted<i>Pseudomonas</i>exotoxin fusion protein for lung cancer therapyFrieder Bauss, Gerhard Niederfellner, Frank Herting et al.|Molecular Oncology|2016Cited by 56
Abstract 4510: RG7787 - a novel de-immunized PE based fusion protein for therapy of mesothelin-positive solid tumorsGerhard Niederfellner, Klaus Bosslet, Frieder Bauss et al.|Cancer Research|2014Cited by 4